XRP crypto eyes rally as price breaks $2.34 level: Is a $6 rally next?
If XRP manages to stay above $2.34, a rally toward $6 is possible, says Arthur Azizov of B2 Ventures.
XRP has been trading within its current range since December. However, the token may be positioning for a major rally. On Wednesday, July 9, it reached a monthly high of $2.40 and managed to sustain its momentum even after a brief correction, trading at $2.37.
Arthur Azizov, founder and investor at B2 Ventures, believes that if XRP holds a key support level, it could push to new highs, potentially even record territory. The first major resistance, he noted, lies at $2.65.
“XRP is currently trading near a key level. If the price manages to hold above $2.34 and stays above this mark, it is likely to move towards a new high around $2.65,” Arthur Azizov, B2 Ventures.
Currently, XRP traders are accumulating tokens, but the price has remained relatively stable. Azizov attributes this to XRP’s tendency to move independently of broader market dynamics. Despite that, the overall outlook for the token is bullish.
“Since XRP has been in accumulation for quite a long time, the outlook remains positive. Most likely, the breakout will be to the upside, with targets in the $4–6 range,” Arthur Azizov, B2 Ventures.
XRP crypto fundamentals remain strong: Azizov
A move above $3.84 would mark a new all-time high for XRP, last reached in January 2018. Several fundamental factors may now support such a move.
For one, XRP has expanded its partnerships with major institutions. Additionally, a growing number of XRP-focused ETF applications have been filed in the U.S., signaling investor anticipation of increased demand.
Its largest ETF, the Teucrium 2x Long Daily XRP, saw its biggest weekly inflows since launch, registering at $158 million in July.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
